Hospital screening study aims to predict superbug infections
NCT ID NCT04715464
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at whether screening hospital patients for multidrug-resistant gram-negative bacteria can predict if they will later develop an infection. Researchers reviewed records of nearly 2,900 adults admitted to an acute care hospital. The goal was to see if early detection and isolation could reduce the spread of these hard-to-treat germs and improve patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help hospitals better identify patients at risk of drug-resistant infections and reduce their spread.
What could go wrong
This is an observational study, not a treatment trial. It only looks at past data, so it cannot prove that screening directly prevents infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.